Michael Molyneaux, MD, Family Medicine, Newport Beach, CA, Passavant Area Hospital

MichaelVanceMolyneauxMD

Family Medicine Newport Beach, CA

Physician

Dr. Molyneaux is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Molyneaux's full profile

Already have an account?

Education & Training

  • Washington University
    Washington University OTHER_TRAINING
  • Olin Business School, Washington UniversityOTHER_TRAINING
  • Dalhousie University Faculty of Medicine
    Dalhousie University Faculty of MedicineMEDICAL_SCHOOL
  • University of Prince Edward Island, CanadaOTHER_TRAINING

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2014 - 2022
  • IL State Medical License
    IL State Medical License 1998 - 2020
  • American Board of Family Medicine Family Medicine

Clinical Trials

Publications & Presentations

Journal Articles

  • Enhanced Angiogenesis and Collagen Density by Living Human Activated Leukocyte Suspension (LHALS) in a Splinted Full-Thickness Dermal Wound Model  
    Shah, V., Li, W., Molyneaux, M, Symposium On Advanced Wound Care, 1/1/2015
  • A Multicenter Randomized Dosing Trial of Spray-Applied Cell Therapy with Human Allogeneic Fibroblasts and Keratinocytes for the Treatment of Chronic Venous Leg Ulcers ...  
    Lancet, 1/1/2014
  • Biological Properties of a Living Human Activated Leukocyte Suspension (LHALS) And Its Association with Wound Healing and Tissue Remodeling  
    Shah, V., Shik, P., Li, W., Molyneaux, M., Zuloff-Shani, A., Wound Healing Society, 1/1/2014
  • Join now to see all

Press Mentions

  • Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the US
    Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the USFebruary 10, 2020
  • Sirnaomics to Present at World Orphan Drug Congress 2019
    Sirnaomics to Present at World Orphan Drug Congress 2019April 08, 2019
  • Sirnaomics Receives FDA Clearance to Initiate Phase 2 Study of STP705 for the Treatment of Non-Melanoma Skin Cancer
    Sirnaomics Receives FDA Clearance to Initiate Phase 2 Study of STP705 for the Treatment of Non-Melanoma Skin CancerJanuary 30, 2019
  • Join now to see all

Hospital Affiliations